41 results
SC 14D9
PNT
POINT Biopharma Global Inc.
13 Oct 23
Tender offer solicitation
7:11am
that there is no financing condition to the completion of the Offer and consummation of the Merger;
the business reputation, capabilities and financial … selected Centerview as its financial advisor in connection with the Transaction based on Centerview’s reputation and experience in the life sciences
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
on the our business, reputation, revenue, financial condition, results of operations and future prospects, in which event the market price of our Common Stock … business, reputation, financial condition, results of operations, revenue and our future prospects. This Form 10-K also contains forward-looking
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
events or circumstances, may have a material adverse effect on the our business, reputation, revenue, financial condition, results of operations … will include an adverse effect on, or a negative impact or harm to, the business, reputation, financial condition, results of operations, revenue and our
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
business, reputation, revenue, financial condition, results of operations and future prospects, in which event the market price of our Common Stock could … , reputation, financial condition, results of operations, revenue and our future prospects. This prospectus also contains forward-looking statements
424B3
tg4buw5ad1oh9k
5 Aug 21
Prospectus supplement
4:26pm
8-K
EX-10.18
ysvchy2yeh 4el3liy7
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
u0n9i f7zf
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
7oy6gpxbru8
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.8
ksaxqr4c9 riq6c
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.7
x2fma fdnfdrq9
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.15
3fcodyenizfym3fz
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.14
fjkt35 f9l
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
0xpti5u6uqq8
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm